Massmedica S.A. (WSE:MSM)
Poland · Delayed Price · Currency is PLN 5.72
0.00 (0.00%)
At close: Aug 11, 2026
Massmedica Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 0.68 | 0.44 | 0.63 | 0.31 | 0.41 | 0.37 |
Depreciation & Amortization | 0.46 | 0.47 | 0.54 | 0.48 | 0.39 | 0.39 |
Other Adjustments | 0.76 | 0.85 | 0.8 | 0.42 | 0.32 | 0.01 |
Change in Receivables | -3.79 | -2.99 | 3.11 | -0.78 | -1.28 | -0.14 |
Changes in Inventories | 1.33 | -1.55 | -3.54 | -1.37 | -0.16 | -1.19 |
Changes in Accounts Payable | 0.59 | 2.81 | -0.01 | 0.26 | 0.47 | 0.76 |
Changes in Other Operating Activities | 0.06 | 0.15 | 0.09 | 0.19 | 0.04 | -1.53 |
Operating Cash Flow | 0.09 | 0.18 | 1.61 | -0.49 | 0.19 | -1.33 |
Operating Cash Flow Growth | -88.85% | -88.61% | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Purchases of Intangible Assets | -0.8 | -0.23 | -1.74 | -0.08 | -0.12 | -0.32 |
Proceeds from Sale of Intangible Assets | - | 0 | 0 | 0 | 0 | 0 |
Purchases of Investments | - | 0 | 0 | 0 | 0 | -0.48 |
Proceeds from Sale of Investments | - | 0 | 0 | 0 | 0.03 | 0 |
Investing Cash Flow | -0.8 | -0.23 | -1.74 | -0.07 | -0.09 | -0.8 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 1.07 | 1.12 | 0.7 | 0.9 | 0.57 | 2.25 |
Net Long-Term Debt Issued (Repaid) | 1.07 | 1.12 | 0.7 | 0.9 | 0.57 | 2.25 |
Issuance of Common Stock | 0.03 | 0 | 0.51 | 0.41 | 0.01 | 0 |
Net Common Stock Issued (Repurchased) | 0.03 | 0 | 0.51 | 0.41 | 0.01 | 0 |
Common Dividends Paid | -0.01 | -0.01 | 0 | 0 | -0.35 | 0 |
Other Financing Activities | -0.9 | -0.91 | -1.01 | -0.83 | -0.32 | 0 |
Financing Cash Flow | 0.19 | 0.2 | 0.2 | 0.48 | -0.09 | 2.25 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | 0 | 0 | 0 | 0 | 0 |
Net Cash Flow | -0.53 | 0.16 | 0.07 | -0.09 | 0.01 | 0.12 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.09 | 0.18 | 1.61 | -0.49 | 0.19 | -1.33 |
Free Cash Flow Growth | -88.85% | -88.61% | - | - | - | - |
FCF Margin | 0.27% | 0.57% | 4.95% | -1.86% | 0.77% | -7.31% |
Free Cash Flow Per Share | 0.04 | 0.08 | 0.67 | -0.20 | 0.08 | -0.55 |
Levered Free Cash Flow | 4.19 | 3.43 | -1.6 | 0.76 | 1.71 | 1.05 |
Unlevered Free Cash Flow | 3.65 | 2.77 | -1.96 | 0.11 | 1.36 | -3.64 |